These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12385053)

  • 21. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
    Golub JE; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; King BS; Efron A; Moore RD; Chaisson RE; Durovni B
    AIDS; 2007 Jul; 21(11):1441-8. PubMed ID: 17589190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation.
    MMWR Recomm Rep; 1998 Apr; 47(RR-5):43-82. PubMed ID: 9572121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
    Dominguez S; Ghosn J; Valantin MA; Schruniger A; Simon A; Bonnard P; Caumes E; Pialoux G; Benhamou Y; Thibault V; Katlama C
    AIDS; 2006 May; 20(8):1157-61. PubMed ID: 16691067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune reactivation and paradoxical worsening in an HIV-infected tuberculosis patient.
    de Lange WC
    Adv Exp Med Biol; 2003; 531():261-6. PubMed ID: 12916798
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
    Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
    Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
    Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
    AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.
    Boulle A; Van Cutsem G; Cohen K; Hilderbrand K; Mathee S; Abrahams M; Goemaere E; Coetzee D; Maartens G
    JAMA; 2008 Aug; 300(5):530-9. PubMed ID: 18677025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection.
    Nowak P; Schvarcz R; Ericzon BG; Flamholc L; Sönnerborg A
    AIDS Res Hum Retroviruses; 2003 Jan; 19(1):13-9. PubMed ID: 12581512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4 responses in the setting or suboptimal virological responses to antiretroviral therapy: features, outcomes, and associated factors.
    Collazos J; Asensi V; Cartón JA;
    AIDS Res Hum Retroviruses; 2009 Jul; 25(7):647-55. PubMed ID: 19621987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory bowel perforation during immune restoration after one year of antiretroviral and antituberculous therapy in an HIV-1-infected patient: report of a case.
    Guex AC; Bucher HC; Demartines N; Flückiger U; Battegay M
    Dis Colon Rectum; 2002 Jul; 45(7):977-8. PubMed ID: 12130890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.
    Srikantiah P; Wong JK; Liegler T; Walusimbi M; Mayanja-Kizza H; Kayanja HK; Mugerwa RD; Charlebois ED; Boom WH; Whalen CC; Havlir DV
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):458-60. PubMed ID: 19011423
    [No Abstract]   [Full Text] [Related]  

  • 38. Changing treatment concepts.
    Katlama C
    HIV Med; 2001 Apr; 2(2):65-7. PubMed ID: 11737380
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality standard for the identification and treatment of persons coinfected with human immunodeficiency virus and Mycobacterium tuberculosis.
    Phair JP; Gross PA; Kaplan JE; Masur H; Holmes KK; Wilfert CM; Martone WJ; Castro KG
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S130-1. PubMed ID: 8547505
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of antiretroviral therapy in patients with Charot-Marie-Tooth disease type 1A.
    Fernández-Torre JL; García-Alcalde M; Alvarez V
    J Neurol; 2002 Jul; 249(7):940-1. PubMed ID: 12212559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.